First Insight | Nutresa 2Q14 Earnings Results
Ideas get bigger when you share them...
August 1, 2014 (www.investorideas.com newswire) 2Q14's revenues stood at COP 1,4 tn, +4,3% YoY, 15% below our estimates and the market's. This poor performance, if compared to 1Q14 figures (+26,7% YoY) was mainly explained by the adoption of the alternative scheme to access currencies in Venezuela known as Sicad II (49,9 VEF/USD), instead of the Cencoex rate (6,3 VEF/USD). By segment, cold cuts was the most affected by VEF's devaluation, showing a decrease of 40% YoY on its 2Q14 revenues (excluding this effect, cold cut's revenues would have grown 23% YoY). At Cencoex rate, consolidated revenues during 2Q14 would have been COP 1,7 tn, +25,8% YoY and 2% above our expectation. It is important to highlight that after this VEF/USD impact, Venezuela participated with only 1,4% of total sales (8,4% in 1Q14). As of June 2014, International sales represented 34.3% of Grupo Nutresa's total sales.
2Q14's EBITDA reached COP 199 bn, +1,3% YoY and 16% below our estimates (15% below market's expectation). Excluding the VEF/USD effect, EBITDA would had been COP 221 bn (+13% YoY). Cold Cuts' was the most affected by de VEF devaluation against USD, showing a decrease of 22% in EBITDA to COP 47 bn (COP 66 bn @6,3 VEFUSD). Consolidated EBITDA Margin stood at 13,9%, pretty in line with our estimates (14%) and in the upper range of the company guidance (12%-14%). We highlight the behavior of Tresmontes Lucchetti's (TMLUC's) EBITDA Margin (13,5%), which showed a recovery from 1Q14 numbers (8,8%).
Net Income during 2Q14 reached COP 83 bn, -14% YoY, 19% below our expectations and 12% below market consensus. The bottom line was affected by lower operating income, greater financial expenses generated by the debt to acquire TMLUC and non-recurring costs related to this operation. However, effective tax rate during 2Q14 (23,5%) was lower than 1Q14 (38,9%) and 2Q13 (31,2%)
Overall, we consider 2Q14 results were negative given the impact of VEF devaluation on international sales. Therefore, 2Q14 was characterize by a slowdown of revenues, EBITDA and Net Income growth vs 1Q14 figures. We expect VEF devaluation to impact financial results from now on, given that the company should have converted the Venezuela's revenues at Sicad II instead of Cencoex. However, we highlight the sustained profitability throughout the year (13,9%) given the company's hedging policy, which has mitigated the pressure on margins due to higher prices in certain raw materials, as well as the improvement in the mix of products sold.
The company will host a conference call to discuss the results next Monday August 04 at 8 AM
Source: Bloomberg, Nutresa, Corredores Asociados
Corredores Asociados S.A. Comisionista de Bolsa is not responsible for investment decisions that may be derived from the information and analyses presented in this document. These decisions, their effects and consequences will be the sole responsibility of the investor. The information published is informative and has been taken from reliable sources, but Corredores Asociados S.A. does not guarantee that they are free of errors. Total or partial reproduction of this document is not allowed without the prior and express authorization of Corredores Asociados S.A.
This news is published on the Investorideas.com Newswire and its syndicated partner network
Get free news alerts:
Sign up here
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and global syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions and advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.